fda warning letters compounded semaglutide september 2025 Beyond the Headlines: to GLP-1 Compounders Why the FDA Issued 30

and More Care Partners MEET THE EXPERTS SmithRx Pharmacy Leadership Team Alan Pannier PharmD, MBA Chief Strategy Officer Alissa Johnson PharmD, MBA, BCPS Senior Director of Clinical Strategy Portia Gifford Moss Dustin Wagstaff PharmD Manager of Clinical Strategy Tanuja Patel PharmD Lead Clinical Account Manager Shelby Hafner PharmD Clinical Strategy Lead GLP-1 Resources Webinar Tuesday, September 30th, 2025 at 9:30am PT / 12:30pm ET The GLP-1 Breakthrough: What it is, Why it Matters, and How to Drive Health Plan Savings About the Webinar A comprehensive weight management strategy is essential for employers looking to take control of your GLP-1 spend without sacrificing care

strain DBF63

Patients who switch between brand-name and compounded versions should monitor for any changes in their response or side effects and report these to their healthcare provider

NBCNews.com

Imad El Asmar , this FDA-approved treatment helps regulate appetite, improve metabolic health, and support long-term weight management

Just be sure that the injection is being administered by a licensed and trained professional